Stroke can come out of the blue, even in people who have been healthy all their lives. Unlike some other health conditions that develop gradually, a stroke occurs suddenly when blood flow to the brain ...

Ischemic stroke is a fatal condition caused by an arterial embolism that blocks the blood flow through the cerebral artery, frequently being a cause of mortality and disability. Fibroblast growth ...

What you don’t know about stroke Stroke can come out of the blue, even in people who have been healthy all their lives.

A study of correlation of the extent and severity of atherosclerosis in the coronary and cerebral arteries and between their individual branches has been undertaken in 200 consecutive medicolegal ...

Ali, H. , Ghaysaa, H. , Jaafar, W. and Malek, M. (2025) Ischemic Stroke Following Coronary Angiography: A Case Report. Case Reports in Clinical Medicine, 14, 123-129. doi: 10.4236/crcm.2025.143016 .

Hypertension (high blood pressure) increases the risk of cardiovascular disease and mortality. Learn how damage from ...

Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Full Year 2024 Conference Call. An audio recording of the webcast will be available shortly after the call today on ...

Jan. 10, 2023 — A program to increase the use of magnesium sulfate, a inexpensive injection that helps prevent cerebral palsy in premature babies, is ... Inflammatory Trigger a New Clue in ...

Impact and progress Frontiers' impact Progress Report 2022 All annual reports ...

DiaMedica Therapeutics Inc. , a clinical-stage biopharmaceutical company focused on developing novel treatments for acute ischemic stroke and preeclampsia, today provided a business update and ...

面对这一困境，基因治疗成为改善脑缺血恢复阶段的潜在 “救星”。基因治疗旨在通过转染外源性核酸（Exogenous Nucleic Acids，ENA）来纠正脑缺血细胞中异常表达的基因。但在实际应用中，却面临着两大棘手问题：一是血脑屏障（Blood-Brain Barrier，BBB）的阻碍，它像一道坚固的城墙，阻止生物制药（分子量大于 500 ...